Join the hands-on workshops to explore Medis QFR® 3.0 at the Training Village at EuroPCR 2024.

Clinical experts will share their experiences with Medis QFR® 3.0 through a combination of presentations and hands-on sessions, and you could interact with them in a friendly and open environment. Be ready to learn how they successfully implemented Medis QFR®, to reach the expected clinical outcomes for better patient care.

Read More

Discover how QFR transforms diagnostic tools for Epicardial and Microvascular Disease in the Cath Lab

– Learn how the newest QFR technology enables coronary physiology analysis in under 30 seconds.
– Understand the role of QFR-IMR as a diagnostic tool for coronary microvascular dysfunction assessment.
– Learn how QFR paves the way for new horizons in treatment options.

Read More

Post-PCI: QFR independently predicts adverse events after stent implantation

Lower values of QFR after complete and successful revascularization is associated with 3-time increase in the risk of subsequent adverse events

Read More

During-PCI: QFR-guided PCI approach improves long term clinical outcomes

In the FAVOR III China trial, we investigated whether utilizing quantitative flow ratio (QFR) guidance in lesion selection for percutaneous coronary intervention (PCI) could improve clinical outcomes compared to standard angiography guidance.

Read More

The next edition of Medis Tips, Tricks, and Shortcuts is now available!

We introduced this new section to share tips across all product lines. By sharing this, we want to transfer the knowledge we receive from you and all your peers and enable the use of Medis software to its full potential.

Read More

Pre-PCI: QFR helps in PCI planning

QFR-based virtual PCI is superior to conventional angiography-based PCI at achieving optimal post-PCI physiology results without significantly increasing procedural time, contrast due or X-ray use.

Read More

Medis QFR® featured in 2 live presentations at CRT 2024!

Many thanks to Yuhei Kobayashi, MD and Prof. Morton Kern for their illuminating presentations at CRT 2024, highlighting the remarkable advancements with Medis QFR.

Read More

QFR proves to be an effective substitute for invasive physiological assessment, due to a high negative predictive value of 92.3%

Dr. Liontou and co-authors, under the leadership of Dr. K. Triantafyllou of the 1st Cardiology Dept. at Evangelismos General Hospital in Athens, Greece, published this interesting paper in Int. J. Cardiovascular Imaging.

Read More

Medis at CRT 2024: Review of the recent QFR Studies, principles of Medis QFR® and why we should use it by Yuhei Kobayashi, MD 

At CRT 2024, Yuhei Kobayashi, MD, will give an insightful session on the review of Medis QFR® and why you should use it. This session will take place on:

March 9, 9:41 AM – 9:49 AM ET in Lincoln

Read More

In daily clinical routine, QFR promises good diagnostic agreement as compared to both iFR and RFR.

Dr. J Stader from the University Hospital Leipzig in Germany, under the supervision of Dr. K Lenk, published this prospective, single-center study, which includes 102 patients with an indication for elective coronary angiography in the Catheterization and Cardiovascular Interventions Journal.

Read More